Drugs / Autologous MSC from bone marrow
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02462330 | Feb 2016 → Dec 2022 | myocardial ischemia | University Hospital, Toulouse | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous MSC from bone marrow | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02462330 ↗ |
| Modality | Cell therapy | “cell therapy group” NCT02462330 ↗ |
| Route | Other | “intramyocardial injections of MSCs” NCT02462330 ↗ |